James Cummings
Direttore Tecnico/Scientifico/R&S presso VAXART, INC.
Patrimonio netto: 117 490 $ in data 31/05/2024
Profilo
James F.
Cummings is currently the Chief Medical Officer at Vaxart, Inc. Prior to this, he served as the President & CEO at ICON Government & Public Health Solutions, Inc. from 2018 to 2021.
He also held positions as Director at OyaGen, Inc., Director-Translational Medicine at Walter Reed Army Institute of Research from 2007 to 2009, Director-Defense Department at Global Emerging Infectious Surveillance & Response System from 2012 to 2015, and VP-Clinical Development & Translational Medicine at Novavax, Inc. from 2015 to 2018.
Cummings received his undergraduate degree from Georgetown University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VAXART, INC.
0.08% | 12/04/2024 | 144 160 ( 0.08% ) | 117 490 $ | 31/05/2024 |
Posizioni attive di James Cummings
| Società | Posizione | Inizio |
|---|---|---|
| VAXART, INC. | Direttore Tecnico/Scientifico/R&S | 27/09/2021 |
Precedenti posizioni note di James Cummings
| Società | Posizione | Fine |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Amministratore Delegato | 01/09/2021 |
| NOVAVAX, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01/08/2015 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | 01/03/2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Direttore/Membro del Consiglio | - |
Formazione di James Cummings
| Georgetown University School of Medicine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Commercial Services |
| Walter Reed Army Institute of Research | |
| Global Emerging Infectious Surveillance & Response System |
- Borsa valori
- Insiders
- James Cummings
